Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers.
Thejus T JayakrishnanYasmine BacaJoanne XiuMehrie PatelBenjamin A WeinbergEmil LouJashodeep DattaMoh'd M KhushmanPat GulhatiSanjay GoelTiago Biachi de CastriaVaia FlorouKanika G NairSuneel D KamathAlok A KhoranaPublished in: JCO precision oncology (2024)
fusion status. Our findings underscore the need for ensuring access to next-generation sequencing testing, including prompt identification of actionable targets.